Post-COVID-19 Symptoms and Heart Disease: Incidence, Prognostic Factors, Outcomes and Vaccination: Results from a Multi-Center International Prospective Registry (HOPE 2).
Ivan Javier Nuñez-GilGisela FeltesMaría C Viana-LlamasSergio Raposeiras-RoubinRodolfo RomeroEmilio Alfonso-RodríguezAitor UribarriFrancesco SantoroVíctor Becerra-MuñozMartino PepeAlex Fernando Castro MejíaJaime Signes-CostaAdelina GonzalezFrancisco MarínJavier Lopez-PaísEnrico CerratoOlalla Vázquez-CancelaCarolina Espejo-PaeresÁlvaro López MasjuanLazar VelickiIbrahim El-BattrawyHarish RamakrishnaAntonio Fernandez-OrtizJulián Perez-Villacastínnull nullPublished in: Journal of clinical medicine (2023)
After surviving the acute phase, patients with underlying heart disease continue to present a more complex clinical profile and worse outcomes including increased mortality. The COVID-19 vaccine could benefit survival in patients with heart disease during follow-up.